{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:00:41Z","timestamp":1787803241149,"version":"build-2784847793"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"am","delay-in-days":295,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005302","name":"University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","award":["R01 DK113080"],"award-info":[{"award-number":["R01 DK113080"]}],"id":[{"id":"10.13039\/100005302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005302","name":"University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","award":["R01 DK130317"],"award-info":[{"award-number":["R01 DK130317"]}],"id":[{"id":"10.13039\/100005302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.mce.2022.111616","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T12:49:16Z","timestamp":1647348556000},"page":"111616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism"],"prefix":"10.1016","volume":"549","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-900X","authenticated-orcid":false,"given":"Weinan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-695X","authenticated-orcid":false,"given":"Sayeepriyadarshini","family":"Anakk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2022.111616_bib1","doi-asserted-by":"crossref","first-page":"36759","DOI":"10.1074\/jbc.M110.166231","article-title":"The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt\/beta-catenin pathways","volume":"285","author":"Abdelkarim","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.mce.2022.111616_bib145","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/hep.29305","article-title":"Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice","volume":"66","author":"Akinrotimi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111616_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12974-017-0833-6","article-title":"Activation of FXR pathway does not alter glial cell function","volume":"14","author":"Albrecht","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.mce.2022.111616_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2020.09.008","article-title":"Fxr-alpha skips alternatively in liver metabolism","volume":"159","author":"Anakk","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111616_bib4","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib5","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0016-5085(03)00388-3","article-title":"FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity","volume":"124","author":"Barbier","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111616_bib6","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/jcbfm.2008.16","article-title":"Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier","volume":"28","author":"Bauer","year":"2008","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.mce.2022.111616_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101992","article-title":"Chenodeoxycholic acid ameliorates AlCl3-induced Alzheimer's disease neurotoxicity and cognitive deterioration via enhanced insulin signaling in rats","volume":"24","author":"Bazzari","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.mce.2022.111616_bib8","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nm.4363","article-title":"Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice","volume":"23","author":"Benoit","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2022.111616_bib9","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1074\/jbc.M808818200","article-title":"Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis","volume":"284","author":"Bhatnagar","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib10","doi-asserted-by":"crossref","first-page":"E716","DOI":"10.1152\/ajpendo.00355.2005","article-title":"Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters","volume":"290","author":"Bilz","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2022.111616_bib11","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1073\/pnas.0400046101","article-title":"Expression and activation of the farnesoid X receptor in the vasculature","volume":"101","author":"Bishop-Bailey","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2022.111616_bib12","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1074\/jbc.RA119.008360","article-title":"Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis","volume":"294","author":"Byun","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcmgh.2021.01.012","article-title":"Transcriptional regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH","volume":"11","author":"Cariello","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mce.2022.111616_bib14","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M510258200","article-title":"The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice","volume":"281","author":"Cariou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib15","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1128\/MCB.01004-12","article-title":"Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes","volume":"33","author":"Caron","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2022.111616_bib16","doi-asserted-by":"crossref","first-page":"19909","DOI":"10.1074\/jbc.M207903200","article-title":"Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib17","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.26187","article-title":"Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111616_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.psychres.2018.04.025","article-title":"Hippocampal FXR plays a role in the pathogenesis of depression: a preliminary study based on lentiviral gene modulation","volume":"264","author":"Chen","year":"2018","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.mce.2022.111616_bib19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0016-5085(03)00896-5","article-title":"Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression","volume":"125","author":"Claudel","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111616_bib20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.molmet.2015.09.005","article-title":"Bioenergetic cues shift FXR splicing towards FXRalpha2 to modulate hepatic lipolysis and fatty acid metabolism","volume":"4","author":"Correia","year":"2015","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.mce.2022.111616_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cmet.2015.01.007","article-title":"MAFG is a transcriptional repressor of bile acid synthesis and metabolism","volume":"21","author":"de Aguiar Vallim","year":"2015","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2022.111616_bib22","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.bbadis.2016.07.012","article-title":"Bile acid receptor agonists INT747 and INT777 decrease oestrogen deficiency-related postmenopausal obesity and hepatic steatosis in mice","volume":"1862","author":"de Oliveira","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2022.111616_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111616_bib24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/db11-0815","article-title":"Bile acids acutely stimulate insulin secretion of mouse beta-cells via farnesoid X receptor activation and K(ATP) channel inhibition","volume":"61","author":"Dufer","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2022.111616_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2022.111616_bib26","doi-asserted-by":"crossref","first-page":"101094","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mce.2022.111616_bib28","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2022.111616_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yexcr.2018.07.004","article-title":"Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia\/reperfusion injury in mice","volume":"371","author":"Gao","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mce.2022.111616_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00008571-200410000-00001","article-title":"Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene","volume":"14","author":"Gnerre","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.mce.2022.111616_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mce.2022.111616_bib32","doi-asserted-by":"crossref","first-page":"29749","DOI":"10.1074\/jbc.274.42.29749","article-title":"Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor\/9-cis-retinoic acid receptor heterodimer","volume":"274","author":"Grober","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbalip.2006.09.018","article-title":"Effects of FXR in foam-cell formation and atherosclerosis development","volume":"1761","author":"Guo","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2022.111616_bib34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bbrc.2020.04.002","article-title":"Fibroblast growth factor 19 alleviates palmitic acid-induced mitochondrial dysfunction and oxidative stress via the AMPK\/PGC-1alpha pathway in skeletal muscle","volume":"526","author":"Guo","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2022.111616_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1086\/649966","article-title":"Diversity of bile salts in fish and amphibians: evolution of a complex biochemical pathway","volume":"83","author":"Hagey","year":"2010","journal-title":"Physiol. Biochem. Zool."},{"key":"10.1016\/j.mce.2022.111616_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00592-020-01652-z","article-title":"Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model","volume":"58","author":"Han","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.mce.2022.111616_bib37","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1194\/jlr.M500390-JLR200","article-title":"Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice","volume":"46","author":"Hanniman","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1194\/jlr.M800619-JLR200","article-title":"Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-\/- and apoE-\/- mice","volume":"50","author":"Hartman","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-2275(20)38873-8","article-title":"Bile salt evolution","volume":"8","author":"Haslewood","year":"1967","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.RES.0000200400.55539.85","article-title":"Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells","volume":"98","author":"He","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2022.111616_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.acthis.2007.08.001","article-title":"Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray","volume":"110","author":"Higashiyama","year":"2008","journal-title":"Acta Histochem"},{"key":"10.1016\/j.mce.2022.111616_bib42","doi-asserted-by":"crossref","first-page":"45685","DOI":"10.1074\/jbc.M404255200","article-title":"Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4","volume":"279","author":"Hirokane","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mce.2012.05.010","article-title":"FXR agonist GW4064 increases plasma glucocorticoid levels in C57BL\/6 mice","volume":"362","author":"Hoekstra","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib44","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","article-title":"Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics","volume":"65","author":"Hofmann","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mce.2022.111616_bib45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1194\/jlr.R000042","article-title":"Bile salts of vertebrates: structural variation and possible evolutionary significance","volume":"51","author":"Hofmann","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib46","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/me.2007-0113","article-title":"In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue","volume":"21","author":"Houten","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.aquatox.2010.02.020","article-title":"Two farnesoid X receptor alpha isoforms in Japanese medaka (Oryzias latipes) are differentially activated in vitro","volume":"98","author":"Howarth","year":"2010","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.mce.2022.111616_bib48","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ijnp\/pyaa039","article-title":"Farnesoid X receptor-mediated cytoplasmic translocation of CRTC2 disrupts CREB-BDNF signaling in hippocampal CA1 and leads to the development of depression-like behaviors in mice","volume":"23","author":"Hu","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.mce.2022.111616_bib49","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1002\/1873-3468.12373","article-title":"Identification of functional farnesoid X receptors in brain neurons","volume":"590","author":"Huang","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mce.2022.111616_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-1119(02)00557-7","article-title":"Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters","volume":"290","author":"Huber","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.mce.2022.111616_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2022.111616_bib52","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2337\/db06-1642","article-title":"Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy","volume":"56","author":"Jiang","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2022.111616_bib53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.mad.2013.08.003","article-title":"Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice","volume":"134","author":"Jiang","year":"2013","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.mce.2022.111616_bib54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2022.111616_bib55","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2022.111616_bib56","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.mce.2022.111616_bib57","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/jhep.2003.50100","article-title":"Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression","volume":"37","author":"Jung","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111616_bib58","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00424-013-1364-3","article-title":"FXR-induced secretion of FGF15\/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway","volume":"466","author":"Jung","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.mce.2022.111616_bib59","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1210\/mend.15.10.0712","article-title":"Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids","volume":"15","author":"Kast","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib60","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib61","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1198363","article-title":"FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis","volume":"331","author":"Kir","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.mce.2022.111616_bib62","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111616_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.08.009","article-title":"Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression","volume":"29","author":"Kong","year":"2019","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.mce.2022.111616_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8915818","article-title":"FXR mediates adenylyl cyclase 8 expression in pancreatic beta-cells","volume":"2019","author":"Kong","year":"2019","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.mce.2022.111616_bib65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mce.2010.06.016","article-title":"Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR","volume":"334","author":"Krasowski","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib66","doi-asserted-by":"crossref","first-page":"G476","DOI":"10.1152\/ajpgi.00430.2005","article-title":"The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes","volume":"290","author":"Landrier","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mce.2022.111616_bib67","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor","volume":"31","author":"Lee","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.mce.2022.111616_bib68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M500417-JLR200","article-title":"FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine","volume":"47","author":"Lee","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib69","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.mce.2022.111616_bib70","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1152\/physiolgenomics.00151.2012","article-title":"Nuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells","volume":"45","author":"Li","year":"2013","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.mce.2022.111616_bib71","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2022.111616_bib72","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.1002\/jcp.27940","article-title":"Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mce.2022.111616_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mce.2016.07.027","article-title":"Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression","volume":"436","author":"Liu","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib74","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1074\/jbc.RA118.001789","article-title":"Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1","volume":"293","author":"Liu","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib75","first-page":"1723","article-title":"Farnesoid X receptor agonist decreases lipid accumulation by promoting hepatic fatty acid oxidation in db\/db mice","volume":"42","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mce.2022.111616_bib76","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/liv.14052","article-title":"Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1","volume":"39","author":"Liu","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.mce.2022.111616_bib77","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1124\/dmd.104.003061","article-title":"Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element","volume":"33","author":"Lu","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.mce.2022.111616_bib78","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI25604","article-title":"Farnesoid X receptor is essential for normal glucose homeostasis","volume":"116","author":"Ma","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2022.111616_bib79","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s11095-013-0986-7","article-title":"Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance","volume":"30","author":"Ma","year":"2013","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.mce.2022.111616_bib80","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.mce.2022.111616_bib81","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/JOE-13-0109","article-title":"FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS","volume":"218","author":"Maneschi","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbadis.2017.10.003","article-title":"Farnesoid X receptor: a \"homeostat\" for hepatic nutrient metabolism","volume":"1864","author":"Massafra","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.mce.2022.111616_bib83","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.numecd.2011.06.008","article-title":"FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity","volume":"23","author":"Mencarelli","year":"2013","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.mce.2022.111616_bib84","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1097-2765(03)00112-6","article-title":"Structural basis for bile acid binding and activation of the nuclear receptor FXR","volume":"11","author":"Mi","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mce.2022.111616_bib85","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(74)91134-9","article-title":"Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia","volume":"2","author":"Miller","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2022.111616_bib86","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1248\/bpb.34.1885","article-title":"Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice","volume":"34","author":"Miyata","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.mce.2022.111616_bib87","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.08005","article-title":"Deciphering the nuclear bile acid receptor FXR paradigm","volume":"8","author":"Modica","year":"2010","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.mce.2022.111616_bib88","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1161\/ATVBAHA.116.308093","article-title":"Farnesoid X receptor and its ligands inhibit the function of platelets","volume":"36","author":"Moraes","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mce.2022.111616_bib89","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111616_bib90","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2022.111616_bib91","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1128\/MCB.23.3.864-872.2003","article-title":"Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol","volume":"23","author":"Otte","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2022.111616_bib92","doi-asserted-by":"crossref","first-page":"166133","DOI":"10.1016\/j.bbadis.2021.166133","article-title":"FXR in liver physiology: multiple faces to regulate liver metabolism","volume":"1867","author":"Panzitt","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.mce.2022.111616_bib93","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.mce.2022.111616_bib94","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib95","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.febslet.2010.04.068","article-title":"The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity","volume":"584","author":"Popescu","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mce.2022.111616_bib96","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","article-title":"FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway","volume":"13","author":"Potthoff","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.mce.2022.111616_bib97","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db11-0030","article-title":"Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity","volume":"60","author":"Prawitt","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2022.111616_bib98","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/eurheartj\/ehs011","article-title":"Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia\/reperfusion injury","volume":"34","author":"Pu","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mce.2022.111616_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108033","article-title":"Knockout of farnesoid X receptor aggravates process of diabetic cardiomyopathy","volume":"161","author":"Qiang","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.mce.2022.111616_bib100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/07853890.2021.1900593","article-title":"Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15\/19 signalling","volume":"53","author":"Qiu","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.mce.2022.111616_bib101","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1053\/j.gastro.2020.07.036","article-title":"FXR isoforms control different metabolic functions in liver cells via binding to specific DNA motifs","volume":"159","author":"Ramos Pittol","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2022.111616_bib102","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbadis.2010.01.002","article-title":"The bile acid sensor FXR regulates insulin transcription and secretion","volume":"1802","author":"Renga","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2022.111616_bib103","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1194\/jlr.M800138-JLR200","article-title":"Evolution of the bile salt nuclear receptor FXR in vertebrates","volume":"49","author":"Reschly","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib104","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/mol.106.023820","article-title":"The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo","volume":"70","author":"Rizzo","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2022.111616_bib105","doi-asserted-by":"crossref","first-page":"17836","DOI":"10.1074\/jbc.M111795200","article-title":"FOR, a novel orphan nuclear receptor related to farnesoid X receptor","volume":"277","author":"Seo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib106","first-page":"72","article-title":"Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors","volume":"9","author":"Seol","year":"1995","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib107","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","article-title":"An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors","volume":"272","author":"Seol","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.mce.2022.111616_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mce.2015.07.012","article-title":"Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance","volume":"414","author":"Shihabudeen","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib109","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2020.04.075","article-title":"Promotion of lipogenesis by PPARgamma-activated FXR expression in adipocytes","volume":"527","author":"Shinohara","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2022.111616_bib110","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.mce.2022.111616_bib111","doi-asserted-by":"crossref","first-page":"42549","DOI":"10.1074\/jbc.M107557200","article-title":"Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor","volume":"276","author":"Song","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib112","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1194\/jlr.M038323","article-title":"Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor","volume":"54","author":"Song","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib113","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1172\/JCI94029","article-title":"RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism","volume":"127","author":"Tarling","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2022.111616_bib114","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo.143.5.8850","article-title":"Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity","volume":"143","author":"Tomlinson","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2022.111616_bib115","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2022.111616_bib116","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.26072","article-title":"Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?","volume":"57","author":"van der Poorten","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111616_bib117","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1194\/jlr.M094508","article-title":"FXR overexpression alters adipose tissue architecture in mice and limits its storage capacity leading to metabolic derangements","volume":"60","author":"van Zutphen","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2022.111616_bib118","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bcp.2013.07.022","article-title":"Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition","volume":"86","author":"Vaquero","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2022.111616_bib119","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3389\/fphys.2020.00650","article-title":"Bile acid supplementation improves murine pancreatitis in association with the gut microbiota","volume":"11","author":"Wan","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.mce.2022.111616_bib120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mce.2022.111616_bib121","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bcp.2017.08.023","article-title":"Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1alpha binding to HNF4alpha","volume":"145","author":"Wang","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2022.111616_bib122","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1681\/ASN.2017020222","article-title":"FXR\/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity","volume":"29","author":"Wang","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mce.2022.111616_bib123","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2022.111616_bib124","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.1074\/jbc.M111.248203","article-title":"Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure","volume":"286","author":"Watanabe","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142865","article-title":"Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis","volume":"131","author":"Wu","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2022.111616_bib126","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/cvr\/cvy093","article-title":"Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction","volume":"114","author":"Xia","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2022.111616_bib127","article-title":"Activation of FXR receptor reduces damage of ET-1 on H9C2 cardiomyocytes by activating AMPK signaling pathway","author":"Xiaoli","year":"2020","journal-title":"Panminerva Med"},{"key":"10.1016\/j.mce.2022.111616_bib128","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/db16-0663","article-title":"An intestinal farnesoid X receptor-ceramide signaling Axis modulates hepatic gluconeogenesis in mice","volume":"66","author":"Xie","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2022.111616_bib129","doi-asserted-by":"crossref","first-page":"15727","DOI":"10.3748\/wjg.v20.i42.15727","article-title":"GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells","volume":"20","author":"Xin","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mce.2022.111616_bib130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mce.2008.11.006","article-title":"The farnesoid X receptor regulates transcription of 3beta-hydroxysteroid dehydrogenase type 2 in human adrenal cells","volume":"299","author":"Xing","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2022.111616_bib131","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.26714","article-title":"Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis","volume":"59","author":"Xu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111616_bib132","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.28712","article-title":"Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice","volume":"64","author":"Xu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2022.111616_bib133","doi-asserted-by":"crossref","first-page":"23158","DOI":"10.1074\/jbc.M314322200","article-title":"Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1","volume":"279","author":"Yamagata","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib134","doi-asserted-by":"crossref","first-page":"41690","DOI":"10.1074\/jbc.M105117200","article-title":"Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.febslet.2007.11.015","article-title":"FXR signaling in metabolic disease","volume":"582","author":"Zhang","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mce.2022.111616_bib136","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1074\/jbc.M209505200","article-title":"Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation","volume":"278","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111616_bib137","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1101\/gad.1138104","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR","volume":"18","author":"Zhang","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.mce.2022.111616_bib138","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2022.111616_bib139","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/01.ATV.0000235697.35431.05","article-title":"FXR deficiency causes reduced atherosclerosis in Ldlr-\/- mice","volume":"26","author":"Zhang","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mce.2022.111616_bib140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/molbev\/msm251","article-title":"Analysis of nuclear receptor pseudogenes in vertebrates: how the silent tell their stories","volume":"25","author":"Zhang","year":"2008","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.mce.2022.111616_bib141","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1073\/pnas.1323977111","article-title":"Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2022.111616_bib142","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/gutjnl-2020-321757","article-title":"FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.mce.2022.111616_bib143","doi-asserted-by":"crossref","first-page":"17027","DOI":"10.1038\/cddiscovery.2017.27","article-title":"The bile acid receptor FXR attenuates acinar cell autophagy in chronic pancreatitis","volume":"3","author":"Zhou","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mce.2022.111616_bib144","article-title":"Lipid droplet structural remodeling in adipose tissue upon caloric excess","author":"Zhou","year":"2021","journal-title":"bioRxiv"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720722000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720722000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:20:48Z","timestamp":1759587648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720722000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":145,"alternative-id":["S0303720722000636"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2022.111616","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2022.111616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111616"}}